#USA #Clinical Trials #Conshohocken #Suvoda #Greenphire

Suvoda and Greenphire Complete Brand Integration

In a significant move towards enhancing the efficiency of clinical trials, Suvoda LLC announced the successful completion of its brand integration with Greenphire. This merger, which was initially revealed in April 2025, marks a transformative phase for both companies as they consolidate their identities under the Suvoda brand. The integration will not only streamline operations but also enhance the experience for participants in clinical trials.

The implications of this transition are substantial. Suvoda now operates with a cohesive brand presence, showcased through its updated website and unified social media channels. The official website, accessible at suvoda.com, provides comprehensive information about the full suite of products that the company offers, tailored to meet the needs of clinical trials.

The New Suvoda Platform

At the heart of Suvoda's transition is its patient-centric technology platform, which simplifies the complexities involved in clinical trials. By integrating multiple technologies into a single platform, Suvoda aims to improve operational efficiency, data quality, and the overall experience for patients and study sites. The platform features eight integrated product offerings, including:

• - IRT (Interactive Response Technology)
• - eCOA (Electronic Clinical Outcome Assessment)
• - Greenphire Patient Payments (previously ClinCard)
• - Greenphire Travel Services (formerly Concierge Services and Connex)
• - eConsent (Electronic Consent)
• - Scheduling (previously ePatient)
• - Greenphire Clinical Finance Suite (including Site Payments and Budgeting Benchmarking)

With these tools, Suvoda seeks to enhance the patient journey by addressing operational, logistical, and financial challenges encountered during clinical trials. The intention is to make these trials more responsive and interconnected, ultimately ensuring a smoother experience for all stakeholders involved.

Visual Identity and User Experience

As part of the branding effort, individuals participating in trials will soon notice the rebranding of Suvoda’s various products, which will feature a newly harmonized color palette and logo. Additionally, the platform plans to introduce a single launchpad that will simplify access to all associated study software, making it easier for sponsors, sites, and patients to navigate.

Suvoda's CEO, Jagath Wanninayake, expressed the company’s mission to ease every aspect of the patient experience, reinforcing their commitment to delivering high-quality solutions that are responsive to the needs of clinical trial participants. As the new brand takes shape, genuine engagement with sponsors, sites, and patients will remain a priority. The aim is to facilitate a more harmonious relationship throughout the clinical trial process, empowering all parties to “Trial wisely.”

Continuing Innovation and Commitment

Despite the challenges inherent in merging two brands, Suvoda is dedicated to retaining a focus on high-quality products and services that drive innovation within the industry. Their advanced technology and expert support are pivotal in navigating the important, often time-sensitive decisions that clinical trials entail. Suvoda is determined to maintain its high customer satisfaction levels, which frequently exceed the industry average.

The company has become a trusted partner for trial sponsors and CROs, managing over 2000 trials across 95 countries. With a presence that spans globally, including offices in Portland, OR, Barcelona, Spain, Bucharest, Romania, and Tokyo, Japan, Suvoda is well-positioned to lead the future of clinical trial technology.

For more information on Suvoda and its offerings, visit suvoda.com or follow them on LinkedIn to stay updated on the latest developments.